questionsmedicales.fr
Techniques d'investigation
Techniques de laboratoire clinique
Techniques microbiologiques
Culture virale
Culture virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Orexin Receptor Antagonists
Diagnostic
5
Culture virale
Diagnostic viral
Échantillons biologiques
Culture virale
Tests de laboratoire
Diagnostic viral
Culture virale
Temps de culture
Infection virale
Culture virale
Symptômes
5
Symptômes
Infection virale
Réponse immunitaire
Infection virale
Asymptomatique
Culture virale
Urgence médicale
Culture virale
Traitements
5
Antiviraux
Traitement antiviral
Culture virale
Traitement antiviral
Antibiotiques
Infection virale
Antiviraux
Réponse immunitaire
Virus
Traitement antiviral
Complications
5
Complications
Infection virale
Complications
État de santé
Personnes âgées
Complications
Facteurs de risque
5
Facteurs de risque
Infection virale
Maladies chroniques
Facteurs de risque
Mode de vie
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Culture virale : Questions médicales les plus fréquentes",
"headline": "Culture virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Culture virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-13",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Culture virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques microbiologiques",
"url": "https://questionsmedicales.fr/mesh/D008828",
"about": {
"@type": "MedicalCondition",
"name": "Techniques microbiologiques",
"code": {
"@type": "MedicalCode",
"code": "D008828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méthode des plages virales",
"alternateName": "Viral Plaque Assay",
"url": "https://questionsmedicales.fr/mesh/D010948",
"about": {
"@type": "MedicalCondition",
"name": "Méthode des plages virales",
"code": {
"@type": "MedicalCode",
"code": "D010948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.970.790"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Culture virale",
"alternateName": "Virus Cultivation",
"code": {
"@type": "MedicalCode",
"code": "D014776",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arvind Varsani",
"url": "https://questionsmedicales.fr/author/Arvind%20Varsani",
"affiliation": {
"@type": "Organization",
"name": "2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA."
}
},
{
"@type": "Person",
"name": "Giacomo Fais",
"url": "https://questionsmedicales.fr/author/Giacomo%20Fais",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Mattia Casula",
"url": "https://questionsmedicales.fr/author/Mattia%20Casula",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Pierluigi Caboni",
"url": "https://questionsmedicales.fr/author/Pierluigi%20Caboni",
"affiliation": {
"@type": "Organization",
"name": "Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Giacomo Cao",
"url": "https://questionsmedicales.fr/author/Giacomo%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The orexin story and orexin receptor antagonists for the treatment of insomnia.",
"datePublished": "2023-04-22",
"url": "https://questionsmedicales.fr/article/37086045",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jsr.13902"
}
},
{
"@type": "ScholarlyArticle",
"name": "Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/37003137",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.npep.2023.102335"
}
},
{
"@type": "ScholarlyArticle",
"name": "Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist.",
"datePublished": "2022-11-16",
"url": "https://questionsmedicales.fr/article/36309969",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/psp4.12877"
}
},
{
"@type": "ScholarlyArticle",
"name": "Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review.",
"datePublished": "2024-09-14",
"url": "https://questionsmedicales.fr/article/39277609",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41398-024-03087-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dual orexin receptor antagonists for the treatment of insomnia: systematic review and network meta-analysis.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37257468",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1768667"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008828"
},
{
"@type": "ListItem",
"position": 5,
"name": "Culture virale",
"item": "https://questionsmedicales.fr/mesh/D014776"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Culture virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Culture virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Culture virale",
"description": "Comment se déroule un test de culture virale ?\nQuels échantillons sont utilisés pour la culture virale ?\nQuels tests complètent la culture virale ?\nCombien de temps prend une culture virale ?\nQuels signes indiquent une infection virale dans une culture ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Orexin+Receptor+Antagonists#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Culture virale",
"description": "Quels symptômes peuvent indiquer une infection virale ?\nLes symptômes varient selon le virus ?\nComment les symptômes évoluent-ils avec une infection virale ?\nLes symptômes sont-ils toujours présents lors d'une culture virale ?\nQuels symptômes nécessitent une culture virale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Orexin+Receptor+Antagonists#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Culture virale",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir les infections virales ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Orexin+Receptor+Antagonists#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Culture virale",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLa culture virale aide-t-elle à choisir un traitement ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Orexin+Receptor+Antagonists#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Culture virale",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes complications sont-elles prévisibles ?\nComment les complications sont-elles traitées ?\nLes enfants sont-ils plus à risque de complications ?\nLes personnes âgées sont-elles plus vulnérables aux complications ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Orexin+Receptor+Antagonists#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Culture virale",
"description": "Quels facteurs augmentent le risque d'infection virale ?\nL'âge influence-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie influence-t-il le risque d'infection virale ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Orexin+Receptor+Antagonists#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se déroule un test de culture virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont utilisés pour la culture virale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests complètent la culture virale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale."
}
},
{
"@type": "Question",
"name": "Combien de temps prend une culture virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection virale dans une culture ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'apparition de cytopathies ou de plaques de lyse indique une infection virale."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec une infection virale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents lors d'une culture virale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une culture virale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, hygiène des mains et éviter le contact avec des personnes infectées."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir les infections virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "La culture virale aide-t-elle à choisir un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont efficaces que contre les infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou modulent la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus peuvent entraîner des complications plus graves chez les enfants."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables aux complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA.
3Structural Biology Research Unit, Department of Integrative Biomedical Sciences, University of Cape Town, Observatory, Cape Town, South Africa.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Center for Advanced Studies, Research and Development in Sardinia (CRS4), Loc. Piscina Manna, Building 1, 09050 Pula, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Bioprocess Engineering and AlgaePARC, Wageningen University and Research, Wageningen, Netherlands.
Biosciences and Aquaculture, Nord University, Bodø, Norway.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Wageningen University & Research, Wageningen, Netherlands.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Wageningen University & Research, Wageningen, Netherlands.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Horticulture and Product Physiology, Department of Plant Sciences, Wageningen University, Wageningen, Netherlands.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America; College of Life Science, Qingdao University, Qingdao, PR China.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America. Electronic address: keg005@uark.edu.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Unité de Biologie Moléculaire du Gène chez les Extrêmophiles, Département de Microbiologie, Institut Pasteur, Paris, 75015, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, F-35000, Rennes, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Energy Joint Genome Institute, Walnut Creek, CA, 94598, USA.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail)-UMR_S 1085, PROTIM, F-35000, Rennes, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Departamento de Producción Vegetal y Microbiología, Evolutionary Genomics Group, Universidad Miguel Hernandez, Alicante, 03550, Spain.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology, The Ohio State University, Columbus, OH, 43210, USA.
Department of Civil, Environmental and Geodetic Engineering, The Ohio State University, Columbus, OH, 43210, USA.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, F-35000, Rennes, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Unité de Biologie Moléculaire du Gène chez les Extrêmophiles, Département de Microbiologie, Institut Pasteur, Paris, 75015, France.
Publications dans "Culture virale" :
Insomnia is present in up to one third of the adult population worldwide, and it can present independently or with other medical conditions such as mental, metabolic, or cardiovascular diseases, which...
The correlation between sleep and epilepsy has been argued over the past decades among scientists. Although the similarities and contrasts between sleep and epilepsy had been considered, their intertw...
The analysis aimed at identifying subject-specific characteristics (covariates) influencing exposure to daridorexant and quantification of covariate effects to determine clinical relevance. Data from ...
Insomnia is highly comorbid in patients with psychiatric disorders, including depression, bipolar disorder, and substance use disorders, and should be treated as an independent condition. Dual orexin ...
Several randomized clinical trials (RCTs) have shown that dual orexin receptor antagonists (DORAs) are effective in the treatment of chronic insomnia. However, the superiority of one particular DORA o...
To perform a network meta-analysis to evaluate the efficacy of different DORAs in patients with chronic insomnia....
The Medline, Embase, and Cochrane Central databases were searched for RCTs that compared DORA with placebo in patients ≥ 18 years of age with a diagnosis of insomnia disorder. We pooled outcomes for w...
We included 10 RCTs with 7,806 patients, 4,849 of whom received DORAs as the intervention. Overall, we found that DORAs were associated with the improvement of all analyzed efficacy outcomes. Concerni...
Our results suggest that DORAs are associated with greater efficacy when compared with placebo in the treatment of insomnia, a complex 24-hour sleep disorder. Additionally, dosing might play an import...
The dual orexin receptor antagonist daridorexant was approved in 2022 in the USA and EU for the treatment of insomnia. The purpose of this study was the identification of its metabolic pathways and th...
Synthesis of drug metabolites, which often have complex structures, is an integral step in the evaluation of drug candidate metabolism, pharmacokinetic (PK) properties, and safety profiles. Frequently...
Up to 40% of patients suffering from anxiety disorders do not benefit from currently available pharmacological treatments. Overactivity of the orexin-1 receptor (OX1R) has been implicated in anxiety- ...
We investigated the pharmacokinetics and characterized the pharmacodynamic (PD) profile of the OX1R antagonist JNJ-61393215 using a battery of central nervous system assessments investigating relevant...
Average time to maximal plasma concentration (...
This observation is in line with our knowledge about the OX1R in preclinical studies, where only inconsistent and non-dose-dependent changes in electroencephalography or other behavioural measures wer...
Lemborexant (LEM) is a dual orexin receptor antagonist (DORA) approved in multiple countries including the USA, Japan, Canada, Australia, and several Asian countries for the treatment of insomnia in a...
This review discusses data for LEM relevant to each of the 8 factors of the United States Controlled Substances Act....
LEM did not demonstrate abuse potential in nonclinical testing and was associated with a low incidence of abuse-related adverse events in clinical study participants with insomnia disorder. Similar to...
LEM, similar to most other prescription insomnia medications, was placed into Schedule IV. However, LEM and other drugs in the DORA class may have a lower potential for abuse as suggested by real-worl...
Benzodiazepines are used in the treatmentof anxiety and insomnia. On the other hand, they not only have side effects such as drowsiness, poor concentration, and muscle relaxation but also persistent c...